Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.

Pharmacoepidemiol Drug Saf · 2017 · PMC5485080 · PMID 28370746

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

For all subgroups combined, there was a borderline significant mean increase of 2.7 DDDs (4.8%) (95%CI 0.1 to 5.3).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.